Gerresheimer up as guidance confirmation reassures, analysts say

SCHOTT Pharma AG & Co KgaA

11/07/2024 07:41

** Shares in Gerresheimer  GXIG.DE  rise around 2% in early
Frankfurt trade after the German medical packaging devices maker
reported a small earnings beat and stuck to its FY guidance
        ** "Good enough," J.P.Morgan says on the Q2 results,
pointing to adjusted EBITDA coming in 2.5% ahead of consensus
  
        ** "We had seen some risk to guidance into these
results, and we expect some further relief in the shares today,"
JPM says
  
        ** Jefferies analysts also note they expect the guidance
confirmation to reassure
  
  
($1 = 0.9230 euros)

 (Reporting by Isabel Demetz)
 ((Isabel.demetz@thomsonreuters.com))